Human Insulin Market Report

Europe Human Insulin Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 22, 2020
  • PAGES：158
  • REPORT CODE：GMM481011
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Human Insulin market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Human Insulin Market Segmentations:

    By Player:

    • Biocon

    • NOVO Nordisk

    • Ypsomed

    • Wockhardt

    • Julphar

    • ELI Lilly

    • Becton, Dickinson

    • Sanofi

    • Biodel

    By Type:

    • Insulin Analogs and Biosimilars

    • Human Insulin Biologics

    By End-User:

    • Short acting

    • Intermediate acting

    • Long acting

    • Pre-mix Insulin

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Insulin Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Human Insulin Market Size and Growth Rate of Insulin Analogs and Biosimilars from 2014 to 2026

    • 1.3.2 Europe Human Insulin Market Size and Growth Rate of Human Insulin Biologics from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Human Insulin Market Size and Growth Rate of Short acting from 2014 to 2026

    • 1.4.2 Europe Human Insulin Market Size and Growth Rate of Intermediate acting from 2014 to 2026

    • 1.4.3 Europe Human Insulin Market Size and Growth Rate of Long acting from 2014 to 2026

    • 1.4.4 Europe Human Insulin Market Size and Growth Rate of Pre-mix Insulin from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Human Insulin Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Insulin by Major Types

      • 3.4.1 Market Size and Growth Rate of Insulin Analogs and Biosimilars

      • 3.4.2 Market Size and Growth Rate of Human Insulin Biologics

    4 Segmentation of Human Insulin Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Insulin by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Human Insulin for Short acting

      • 4.4.2 Market Size and Growth Rate of Human Insulin for Intermediate acting

      • 4.4.3 Market Size and Growth Rate of Human Insulin for Long acting

      • 4.4.4 Market Size and Growth Rate of Human Insulin for Pre-mix Insulin

    5 Market Analysis by Major Regions

    • 5.1 Europe Human Insulin Production Analysis by Top Regions

    • 5.2 Europe Human Insulin Consumption Analysis by Top Regions

    • 5.3 Europe Human Insulin Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.3 France Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Production, Import, Consumption and Export Analysis

    6 Product Circulation of Human Insulin Market among Top Countries

    • 6.1 Top 5 Export Countries in Human Insulin Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Human Insulin Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Human Insulin Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Human Insulin Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Human Insulin Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Human Insulin Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Human Insulin Landscape Analysis

    • 7.1 Germany Human Insulin Landscape Analysis by Major Types

    • 7.2 Germany Human Insulin Landscape Analysis by Major End-Users

    8. UK Human Insulin Landscape Analysis

    • 8.1 UK Human Insulin Landscape Analysis by Major Types

    • 8.2 UK Human Insulin Landscape Analysis by Major End-Users

    9. France Human Insulin Landscape Analysis

    • 9.1 France Human Insulin Landscape Analysis by Major Types

    • 9.2 France Human Insulin Landscape Analysis by Major End-Users

    10. Italy Human Insulin Landscape Analysis

    • 10.1 Italy Human Insulin Landscape Analysis by Major Types

    • 10.2 Italy Human Insulin Landscape Analysis by Major End-Users

    11. Spain Human Insulin Landscape Analysis

    • 11.1 Spain Human Insulin Landscape Analysis by Major Types

    • 11.2 Spain Human Insulin Landscape Analysis by Major End-Users

    12. Poland Human Insulin Landscape Analysis

    • 12.1 Poland Human Insulin Landscape Analysis by Major Types

    • 12.2 Poland Human Insulin Landscape Analysis by Major End-Users

    13. Russia Human Insulin Landscape Analysis

    • 13.1 Russia Human Insulin Landscape Analysis by Major Types

    • 13.2 Russia Human Insulin Landscape Analysis by Major End-Users

    14. Switzerland Human Insulin Landscape Analysis

    • 14.1 Switzerland Human Insulin Landscape Analysis by Major Types

    • 14.2 Switzerland Human Insulin Landscape Analysis by Major End-Users

    15. Turkey Human Insulin Landscape Analysis

    • 15.1 Turkey Human Insulin Landscape Analysis by Major Types

    • 15.2 Turkey Human Insulin Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Landscape Analysis by Top Countries

      • 16.3.1 Denmark Human Insulin Market Volume and Growth Rate

      • 16.3.2 Finland Human Insulin Market Volume and Growth Rate

      • 16.3.3 Norway Human Insulin Market Volume and Growth Rate

      • 16.3.4 Sweden Human Insulin Market Volume and Growth Rate

      • 16.3.6 Iceland Human Insulin Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Landscape Analysis by Top Countries

      • 17.3.1 Belgium Human Insulin Market Volume and Growth Rate

      • 17.3.2 Netherlands Human Insulin Market Volume and Growth Rate

      • 17.3.3 Luxembourg Human Insulin Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Landscape Analysis by Top Countries

      • 18.3.1 Estonia Human Insulin Market Volume and Growth Rate

      • 18.3.2 Latvia Human Insulin Market Volume and Growth Rate

      • 18.3.3 Lithuania Human Insulin Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Biocon

      • 19.1.1 Biocon Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 NOVO Nordisk

      • 19.2.1 NOVO Nordisk Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Ypsomed

      • 19.3.1 Ypsomed Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Wockhardt

      • 19.4.1 Wockhardt Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Julphar

      • 19.5.1 Julphar Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 ELI Lilly

      • 19.6.1 ELI Lilly Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Becton, Dickinson

      • 19.7.1 Becton, Dickinson Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Sanofi

      • 19.8.1 Sanofi Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Biodel

      • 19.9.1 Biodel Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    The List of Tables and Figures (Totals 88 Figures and 157 Tables)

    • Figure Product Picture

    • Figure Europe Human Insulin Market Size and Growth Rate of Insulin Analogs and Biosimilars from 2014 to 2026

    • Figure Europe Human Insulin Market Size and Growth Rate of Human Insulin Biologics from 2014 to 2026

    • Figure Europe Human Insulin Market Size and Growth Rate of Short acting from 2014 to 2026

    • Figure Europe Human Insulin Market Size and Growth Rate of Intermediate acting from 2014 to 2026

    • Figure Europe Human Insulin Market Size and Growth Rate of Long acting from 2014 to 2026

    • Figure Europe Human Insulin Market Size and Growth Rate of Pre-mix Insulin from 2014 to 2026

    • Figure Germany Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure UK Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure France Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Human Insulin Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Human Insulin Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Human Insulin

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Insulin by Different Types from 2014 to 2026

    • Table Consumption Share of Human Insulin by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Insulin Analogs and Biosimilars

    • Figure Market Size and Growth Rate of Human Insulin Biologics

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Human Insulin by Different End-Users from 2014 to 2026

    • Table Consumption Share of Human Insulin by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Short acting

    • Figure Market Size and Growth Rate of Intermediate acting

    • Figure Market Size and Growth Rate of Long acting

    • Figure Market Size and Growth Rate of Pre-mix Insulin

    • Table Europe Human Insulin Production by Major Regions

    • Table Europe Human Insulin Production Share by Major Regions

    • Figure Europe Human Insulin Production Share by Major Countries and Regions in 2014

    • Table Europe Human Insulin Consumption by Major Regions

    • Table Europe Human Insulin Consumption Share by Major Regions

    • Table Germany Human Insulin Production, Import, Consumption and Export Analysis

    • Table UK Human Insulin Production, Import, Consumption and Export Analysis

    • Table France Human Insulin Production, Import, Consumption and Export Analysis

    • Table Italy Human Insulin Production, Import, Consumption and Export Analysis

    • Table Spain Human Insulin Production, Import, Consumption and Export Analysis

    • Table Poland Human Insulin Production, Import, Consumption and Export Analysis

    • Table Russia Human Insulin Production, Import, Consumption and Export Analysis

    • Table Switzerland Human Insulin Production, Import, Consumption and Export Analysis

    • Table Turkey Human Insulin Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Human Insulin Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Human Insulin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Human Insulin Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Human Insulin Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Human Insulin Consumption by Types from 2014 to 2026

    • Table Germany Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Germany Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Germany Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table UK Human Insulin Consumption by Types from 2014 to 2026

    • Table UK Human Insulin Consumption Share by Types from 2014 to 2026

    • Table UK Human Insulin Consumption by End-Users from 2014 to 2026

    • Table UK Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table France Human Insulin Consumption by Types from 2014 to 2026

    • Table France Human Insulin Consumption Share by Types from 2014 to 2026

    • Table France Human Insulin Consumption by End-Users from 2014 to 2026

    • Table France Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Italy Human Insulin Consumption by Types from 2014 to 2026

    • Table Italy Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Italy Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Italy Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Spain Human Insulin Consumption by Types from 2014 to 2026

    • Table Spain Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Spain Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Spain Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Poland Human Insulin Consumption by Types from 2014 to 2026

    • Table Poland Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Poland Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Poland Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Russia Human Insulin Consumption by Types from 2014 to 2026

    • Table Russia Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Russia Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Russia Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Human Insulin Consumption by Types from 2014 to 2026

    • Table Switzerland Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Switzerland Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Switzerland Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Human Insulin Consumption by Types from 2014 to 2026

    • Table Turkey Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Turkey Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Turkey Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Insulin Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Insulin Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Insulin Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Human Insulin Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of NOVO Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NOVO Nordisk

    • Figure Sales and Growth Rate Analysis of NOVO Nordisk

    • Figure Revenue and Market Share Analysis of NOVO Nordisk

    • Table Product and Service Introduction of NOVO Nordisk

    • Table Company Profile and Development Status of Ypsomed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ypsomed

    • Figure Sales and Growth Rate Analysis of Ypsomed

    • Figure Revenue and Market Share Analysis of Ypsomed

    • Table Product and Service Introduction of Ypsomed

    • Table Company Profile and Development Status of Wockhardt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wockhardt

    • Figure Sales and Growth Rate Analysis of Wockhardt

    • Figure Revenue and Market Share Analysis of Wockhardt

    • Table Product and Service Introduction of Wockhardt

    • Table Company Profile and Development Status of Julphar

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Julphar

    • Figure Sales and Growth Rate Analysis of Julphar

    • Figure Revenue and Market Share Analysis of Julphar

    • Table Product and Service Introduction of Julphar

    • Table Company Profile and Development Status of ELI Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ELI Lilly

    • Figure Sales and Growth Rate Analysis of ELI Lilly

    • Figure Revenue and Market Share Analysis of ELI Lilly

    • Table Product and Service Introduction of ELI Lilly

    • Table Company Profile and Development Status of Becton, Dickinson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton, Dickinson

    • Figure Sales and Growth Rate Analysis of Becton, Dickinson

    • Figure Revenue and Market Share Analysis of Becton, Dickinson

    • Table Product and Service Introduction of Becton, Dickinson

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Biodel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biodel

    • Figure Sales and Growth Rate Analysis of Biodel

    • Figure Revenue and Market Share Analysis of Biodel

    • Table Product and Service Introduction of Biodel

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US